The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
13-cis-Retinoic Acid in the Treatment of Oral Leukoplakia
Abstract
13-cis-Retinoic acid has been reported to be effective in treating oral leukoplakia. We randomly assigned 44 patients with this disease to receive 13-cis-retinoic acid (24 patients) or placebo (20), 1 to 2 mg per kilogram of body weight per day for three months, and followed them for six months. There were major decreases in the size of the lesions in 67 percent (16 patients) of those given the drug and in 10 percent (2 patients) of those given placebo (P = 0.0002); dysplasia was reversed in 54 percent (13 patients) of the drug group and in 10 percent (2 patients) of the placebo group (P = 0.01). The clinical response to the drug correlated with the histologic response in 56 percent (9 of 16) of the patients evaluated. Relapse occurred in 9 of 16 patients two to three months after treatment ended. The toxic effects of the drug were acceptable in all but two patients. Cheilitis, facial erythema, and dryness and peeling of the skin were common; conjunctivitis and hypertriglyceridemia also occurred. All adverse reactions could be reversed by reducing the dose or temporarily discontinuing the drug. We conclude that 13-cis-retinoic acid, even in short-term use, appears to be an effective treatment for oral leukoplakia and has an acceptable level of toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
Breitman, T. R., Selonick, S. E., & Collins, S. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2936 · Cited by 1,966
Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells
Lotan, R. (1980) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(80)90021-9 · Cited by 1,072
Oral leukoplakia and malignant transformation. A follow-up study of 257 patients
Jr, S. S., Gorsky, M., & Ms, F. L. (1984) · Cancer · doi:10.1002/1097-0142(19840201)53:3<563::aid-cncr2820530332>3.0.co;2-f · Cited by 1,037
Vitamin A and retinoids in health and disease
Epstein, F. H., & Goodman, D. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198404193101605 · Cited by 553
Prolonged Remissions of Cystic and Conglobate Acne with 13-cis-Retinoic Acid
Peck, G. L., Olsen, T. G., Yoder, F. W., Strauss, J. S., Downing, D. T., Pandya, M., Butkus, D., & Arnaud-Battandier, J. (1979) · New England Journal of Medicine · doi:10.1056/nejm197902153000701 · Cited by 519
Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion
Slaga, T. J., Fischer, S. M., Nelson, K., & Gleason, G. L. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.6.3659 · Cited by 331
DEGREE OF BRONCHIAL METAPLASIA IN HEAVY SMOKERS AND ITS REGRESSION AFTER TREATMENT WITH A RETINOID
Gouveia, J., Hercend, T., Lemaigre, G., Mathé, G., Gros, F., Santelli, G., Homasson, J.-P., Angebault, M., Lededente, A., Parrot, R., et al. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92623-x · Cited by 103
13-cis retinoic acid treatment for myelodysplastic syndromes.
Picozzi, V. J., Swanson, G. F., Morgan, R., Hecht, F., & Greenberg, P. L. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.4.589 · Cited by 91
Meyskens, F. L., Goodman, G. E., Alberts, D. S., & Itri, L. M. (1985) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(85)80040-8 · Cited by 69
Self-citationRetinoids and Chemoprevention of Cancer
Sporn, M. B., & Newton, D. L. (1981) · Springer eBooks · doi:10.1007/978-1-4615-9218-1_3 · Cited by 49
Cited by
The promise of retinoids to fight against cancer
Altucci, L., & Gronemeyer, H. (2001) · Nature Reviews Cancer · doi:10.1038/35106036 · Cited by 773
Smith, M. A., Parkinson, D. R., Cheson, B. D., & Friedman, M. A. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.839 · Cited by 486
Cancer Prevention With Natural Compounds
Gullett, N. P., Ruhul Amin, A. R. M., Bayraktar, S., Pezzuto, J. M., Shin, D. M., Khuri, F. R., Aggarwal, B. B., Surh, Y.-J., & Kucuk, O. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.06.014 · Cited by 485
Retinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
Comparison of Low-Dose Isotretinoin with Beta Carotene to Prevent Oral Carcinogenesis
Lippman, S. M., Batsakis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H., & Hong, W. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280103 · Cited by 401
Self-citation
Metadata
- Authors
- Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P., & Strong, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1986-12-11
- Volume
- 315
- Issue
- 24
- Pages
- 1501-1505
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2339318589
- Cited by
- 819
- References
- 11
- FWCI
- 25.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 13-cis-Retinoic Acid in the Treatment of Oral Leukoplakia. https://app.cochat.ai/papers/10.1056/nejm198612113152401
- The paper
- Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P., & Strong, S. (1986). 13-cis-Retinoic Acid in the Treatment of Oral Leukoplakia. New England Journal of Medicine. https://doi.org/10.1056/nejm198612113152401
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.